Symbol: |
TBC1D2
|
Description: |
TBC1 domain family, member 2 [Source:HGNC Symbol;Acc:18026]
|
Location: |
Chr9:100961311-101017915[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:479
Gene |
Compound |
Gen_sig |
Exp_pattern |
TBC1D2 |
NSC 721536 |
0.009 |
Up |
TBC1D2 |
NSC 721875 |
0.041 |
Up |
TBC1D2 |
2-fluorphenylhydrazone alpha-lapachone |
0.001 |
Down |
TBC1D2 |
NSC 722222 |
0.001 |
Up |
TBC1D2 |
4-[4-(2-Diethylamino-ethylamino)-naphthalen-1-ylazo]-benzene sulfonamide |
0.036 |
Up |
TBC1D2 |
NSC 722876 |
0.001 |
Up |
TBC1D2 |
NSC 722985 |
0.035 |
Up |
TBC1D2 |
NSC 723548 |
0.012 |
Up |
TBC1D2 |
Pyridone-OCH3 |
0.001 |
Down |
TBC1D2 |
(Thiopen-2-ylmethylene-hydrazinocarbonylmethylsulfanyl) acetic acid(thiopen-2-ylmethylene)-hydrazide |
0.022 |
Down |
TBC1D2 |
(1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]he xadec-9-ene |
0.032 |
Up |
TBC1D2 |
(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.04,13.08,13]hexadecane |
0.038 |
Up |
TBC1D2 |
ARTEMISININ DIMER HEMISUCCINATE |
0.027 |
Up |
TBC1D2 |
Dasatinib |
0.003 |
Down |
TBC1D2 |
NSC 732719 |
0.002 |
Up |
Expression pattern: Sensitivity / Resistance
Total:32 Current:29
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:5
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:118
Total:8 Current:1
[First] [Prev]  Next Last 
|